Atlas Trials

Absorption & Elimination of Radiolabelled GSK2269557

Clinical trial NCT03315559 · COMPLETED

Trial details

NCT number
NCT03315559
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pulmonary Disease, Chronic Obstructive
Start date
2017-11-14
Primary completion
2017-12-22
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.